Adicet Bio, Inc. Gain (Loss) on Disposition of Assets
Adicet Bio, Inc. (ACET) reported Gain (Loss) on Disposition of Assets of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-08-05
- Adicet Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $0.00.
- Adicet Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $0.00.
- Adicet Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Adicet Bio, Inc. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- Adicet Bio, Inc. gain (loss) on disposition of assets for fiscal 2025 was -$103.00K.
- Adicet Bio, Inc. gain (loss) on disposition of assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Adicet Bio, Inc. gain (loss) on disposition of assets for fiscal 2023 was $4.00K.
- Adicet Bio, Inc. gain (loss) on disposition of assets for fiscal 2022 was -$55.00K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 9 month as first filed | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | -$103.00K 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$103.00K 10-Q · filed 2025-11-05 | ||||
| 2025-06-30 | -$103.00K 10-Q · filed 2026-08-05 | |||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $0.00 derived: sum of 2 quarters · filed 2026-03-12 | $0.00 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||||
| 2023-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $4.00K derived: sum of 2 quarters · filed 2024-03-19 | $4.00K derived: sum of 3 quarters · filed 2024-03-19 | $4.00K 10-K · filed 2024-03-19 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $0.00 10-Q · filed 2023-11-08 | $0.00 derived: sum of 4 quarters · filed 2024-03-19 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2024-03-19 | -$37.00K derived: sum of 4 quarters · filed 2024-03-19 | ||
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | -$37.00K derived: sum of 3 quarters · filed 2024-03-19 | -$37.00K derived: sum of 4 quarters · filed 2024-03-19 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$37.00K derived: sum of 2 quarters · filed 2024-03-19 | -$37.00K derived: sum of 3 quarters · filed 2024-03-19 | -$55.00K 10-K · filed 2024-03-19 | ||
| 2022-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$37.00K derived: sum of 2 quarters · filed 2023-11-08 | -$55.00K 10-Q · filed 2023-11-08 | $104.00K derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$18.00K 10-Q · filed 2023-08-09 | $141.00K derived: sum of 3 quarters · filed 2023-08-09 | -$49.00K derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-03-31 | -$18.00K 10-Q · filed 2023-05-09 | $141.00K derived: sum of 2 quarters · filed 2023-05-09 | -$49.00K derived: sum of 3 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | -$31.00K derived: sum of 2 quarters · filed 2022-11-08 | -$31.00K 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$190.00K 10-Q · filed 2022-11-08 | ||||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-10 | |||||
| 2019-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $27.00K 10-K · filed 2021-03-12 | -$53.00K 10-K · filed 2020-03-12 | |||
| 2019-09-30 | -$3.00K 10-Q · filed 2020-11-05 | -$35.00K 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |